Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Autor: Jain MD; Moffitt Cancer Center, Tampa, FL., Spiegel JY; University of Miami Miller School of Medicine, Miami, FL., Nastoupil LJ; The University of Texas MD Anderson Cancer Center, Houston, TX., Tamaresis J; Stanford University Medical Center, Stanford, CA., Ghobadi A; Washington University School of Medicine and Siteman Cancer Center, St Louis, MO., Lin Y; Mayo Clinic, Rochester, MN., Lekakis L; University of Miami Miller School of Medicine, Miami, FL., Reagan P; University of Rochester Medical Center, Rochester, NY., Oluwole O; Vanderbilt-Ingram Cancer Center, Nashville, TN., McGuirk J; University of Kansas Medical Center, Kansas City, KS., Deol A; Karmanos Center Institute/Wayne State University, Detroit, MI., Dorritie KA; UPMC Hillman Cancer Center, Pittsburgh, PA., Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA., Goy A; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ., Hill BT; Cleveland Clinic, Cleveland, OH., Andreadis C; University of CA San Francisco, San Francisco, CA., Munoz J; Mayo Clinic Arizona, Phoenix, AZ., Ulrickson M; Banner MD Anderson Cancer Center, Gilbert, AZ., Westin J; The University of Texas MD Anderson Cancer Center, Houston, TX., Chavez JC; Moffitt Cancer Center, Tampa, FL., Patel D; Washington University School of Medicine and Siteman Cancer Center, St Louis, MO., Jacobs MT; Washington University School of Medicine and Siteman Cancer Center, St Louis, MO., Bansal R; Mayo Clinic, Rochester, MN., Bennani NN; Mayo Clinic, Rochester, MN., Patel VG; Vanderbilt-Ingram Cancer Center, Nashville, TN., Rapoport AP; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD., Vose JM; University of Nebraska Medical Center, Omaha, NE., Miklos DB; Stanford University Medical Center, Stanford, CA., Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX., Locke FL; Moffitt Cancer Center, Tampa, FL., Lunning M; University of Nebraska Medical Center, Omaha, NE., Dahiya S; Stanford University Medical Center, Stanford, CA.; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 20; Vol. 42 (30), pp. 3581-3592. Date of Electronic Publication: 2024 Aug 02.

Engineered CD47 protects T cells for enhanced antitumour immunity.

Autor: Yamada-Hunter SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Theruvath J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., McIntosh BJ; Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA., Freitas KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA., Lin F; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Masters in Translational Research and Applied Medicine Program, Stanford University School of Medicine, Stanford, CA, USA., Radosevich MT; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Leruste A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Dhingra S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Martinez-Velez N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Xu P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Huang J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Delaidelli A; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Desai MH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Polak R; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., May A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA., Labanieh L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA., Bjelajac J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA., Murty T; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Program in Biophysics, Stanford University, Stanford, CA, USA.; Medical Scientist Training Program, Stanford University, Stanford, CA, USA., Ehlinger Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mount CW; Medical Scientist Training Program, Stanford University, Stanford, CA, USA.; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.; Neurosciences Program, Stanford University, Stanford, CA, USA., Chen Y; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Heitzeneder S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Marjon KD; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Banuelos A; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Khan O; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Medical Scientist Training Program, Stanford University, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wasserman SL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Spiegel JY; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Fernandez-Pol S; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Kuo CJ; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Sorensen PH; British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Monje M; Medical Scientist Training Program, Stanford University, Stanford, CA, USA.; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.; Neurosciences Program, Stanford University, Stanford, CA, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Majzner RG; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Weissman IL; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Sotillo E; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Cochran JR; Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA.; Department of Chemical Engineering, Stanford University, Stanford, CA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.; Cancer Biology Program, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Ludwig Center for Cancer Stem Cell Research and Medicine, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.

Publikováno v: Nature [Nature] 2024 Jun; Vol. 630 (8016), pp. 457-465. Date of Electronic Publication: 2024 May 15.

Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.

Autor: Sworder BJ; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Kurtz DM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Alig SK; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Shukla N; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Garofalo A; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Macaulay CW; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Shahrokh Esfahani M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Olsen MN; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hamilton J; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hosoya H; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Hamilton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Spiegel JY; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Baird JH; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sugio T; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Carleton M; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Craig AFM; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Younes SF; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Sheybani ND; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Schroers-Martin JG; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA., Liu CL; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Oak JS; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Jin MC; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Beygi S; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA., Hüttmann A; Department of Hematology, University Hospital of Essen, Essen, Germany., Hanoun C; Department of Hematology, University Hospital of Essen, Essen, Germany., Dührsen U; Department of Hematology, University Hospital of Essen, Essen, Germany., Westin JR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Khodadoust MS; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA., Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA., Majzner RG; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA 94305, USA., Diehn M; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA 94305, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA 94305, USA., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University, 265 Campus Drive, Stanford, CA 94305, USA; Stanford Cancer Institute, Stanford University, Stanford, CA 94305, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA 94305, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: arasha@stanford.edu.

Publikováno v: Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 210-225.e5. Date of Electronic Publication: 2022 Dec 29.

Post-infusion CAR T Reg cells identify patients resistant to CD19-CAR therapy.

Autor: Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA., Spiegel JY; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Malipatlolla MB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Ehlinger ZJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Kurra S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Homer Stryker M.D. School of Medicine, Western Michigan University, Kalamazoo, MI, USA., Desai MH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Reynolds WD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wong Lin A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Research Lab, Flow Cytometry Core Facility, University of California, Berkeley, Berkeley, CA, USA., Vandris P; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wu F; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Prabhu S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hamilton MP; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Tamaresis JS; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Hanson PJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Syncopation Life Sciences, San Mateo, CA, USA., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Baird JH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma, City of Hope National Medical Center, Duarte, CA, USA., Muffly L; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Claire GK; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Craig J; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kong KA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Wagh D; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Coller J; Stanford Genomics Facility, Stanford University School of Medicine, Stanford, CA, USA., Bendall SC; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Tibshirani RJ; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Statistics, Stanford University, Stanford, CA, USA., Plevritis SK; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.; Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA., Miklos DB; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. dmiklos@stanford.edu., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. cmackall@stanford.edu.

Publikováno v: Nature medicine [Nat Med] 2022 Sep; Vol. 28 (9), pp. 1860-1871. Date of Electronic Publication: 2022 Sep 12.

Imagining the cell therapist: Future CAR T cell monitoring and intervention strategies to improve patient outcomes.

Autor: Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center, and Department of Oncologic Sciences Morsani College of Medicine University of South Florida Tampa Florida USA., Spiegel JY; Division of Transplant and Cellular Therapy Sylvester Comprehensive Cancer Center University of Miami Miami Florida USA.

Publikováno v: EJHaem [EJHaem] 2021 Dec 08; Vol. 3 (Suppl 1), pp. 46-53. Date of Electronic Publication: 2021 Dec 08 (Print Publication: 2022).